These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25118620)
1. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset. Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620 [TBL] [Abstract][Full Text] [Related]
2. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice. Fujiki N; Cheng T; Yoshino F; Nishino S Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673 [TBL] [Abstract][Full Text] [Related]
3. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672 [TBL] [Abstract][Full Text] [Related]
4. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Blanco-Centurion C; Liu M; Konadhode R; Pelluru D; Shiromani PJ Sleep; 2013 Jan; 36(1):31-40. PubMed ID: 23288969 [TBL] [Abstract][Full Text] [Related]
5. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861 [TBL] [Abstract][Full Text] [Related]
6. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635 [TBL] [Abstract][Full Text] [Related]
8. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. Liu M; Blanco-Centurion C; Konadhode R; Begum S; Pelluru D; Gerashchenko D; Sakurai T; Yanagisawa M; van den Pol AN; Shiromani PJ J Neurosci; 2011 Apr; 31(16):6028-40. PubMed ID: 21508228 [TBL] [Abstract][Full Text] [Related]
10. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957 [TBL] [Abstract][Full Text] [Related]
11. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602 [TBL] [Abstract][Full Text] [Related]
12. Behavioral state instability in orexin knock-out mice. Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084 [TBL] [Abstract][Full Text] [Related]
13. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349 [TBL] [Abstract][Full Text] [Related]
14. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772 [TBL] [Abstract][Full Text] [Related]
15. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676 [TBL] [Abstract][Full Text] [Related]
16. Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons. Lo Martire V; Silvani A; Bastianini S; Berteotti C; Zoccoli G PLoS One; 2012; 7(10):e47032. PubMed ID: 23056568 [TBL] [Abstract][Full Text] [Related]
17. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Okuro M; Fujiki N; Kotorii N; Ishimaru Y; Sokoloff P; Nishino S Sleep; 2010 Jul; 33(7):930-42. PubMed ID: 20614853 [TBL] [Abstract][Full Text] [Related]
18. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model. Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540 [TBL] [Abstract][Full Text] [Related]
19. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Kaushik MK; Aritake K; Imanishi A; Kanbayashi T; Ichikawa T; Shimizu T; Urade Y; Yanagisawa M Proc Natl Acad Sci U S A; 2018 Jun; 115(23):6046-6051. PubMed ID: 29784823 [TBL] [Abstract][Full Text] [Related]